Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells

Molecular Immunology

Volumn 41, Issue 1, 2004, Pages 19-28

  Kölln, Johanna ^a   Matzas, Mark ^a   Jänner, Nathalie ^a   Mix, Thorsten ^a   Klensang, Katrin ^a   Bredehorst, Reinhard ^a   Spillner, Edzard ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

CDR; Chinese hamster ovary; CHO; Cobra Venom Factor; CVF; GVBS++; hC3; human C3; native CVF; nCVF; rCVF; recombinant CVF; scFv; single chain fragment variable; veronal buffered saline with gelantine, MgCl2 and CaCl2

Indexed keywords

COBROTOXIN; COMPLEMENT COMPONENT C3;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHIMERA; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOPRECIPITATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; SURFACE PROPERTY;

AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; COBRA VENOMS; COMPLEMENT C3; COMPLEMENT INACTIVATOR PROTEINS; CRICETINAE; CRICETULUS; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PRECIPITIN TESTS; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; TRANSFECTION;

CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 2342486011     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.02.003     Document Type: Article

References (32)

1. Alper C.A., Balavitch D. Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement). Science. 191:1976;1275-1276
2. Ausubel, F.M., 1996. Current Protocols in Molecular Biology. Wiley Interscience, New York.
3. Ballow M., Cochrane C.G. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J. Immunol. 103:1969;944-952
4. Barbas C.F.3rd, Bain J.D., Hoekstra D.M., Lerner R.A. Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4457-4461
5. Davis A.E.3rd, Harrison R.A. Structural characterisation of factor I mediated cleavage of the third component of complement. Biochemistry. 21:1982;5745-5749
6. Gowda D.C., Petrella E.C., Raj T.T., Bredehorst R., Vogel C.W. Immunoreactivity and function of oligosaccharides in cobra venom factor. J. Immunol. 152:1994;2977-2986
7. Fritzinger D.C., Bredehorst R., Vogel C.W. Molecular cloning and derived primary structure of cobra venom factor. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12775-12779
8. Griffiths A.D., Williams S.C., Hartley O., Tomlinson I.M., Waterhouse P., Crosby W.L., Kontermann R.E., Jones P.T., Low N.M., Allison T.J., et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:1994;3245-3260
9. Grossmann M., Wong R., Teh N.G., Tropea J.E., East-Palmer J., Weintraub B.D., Szkudlinski M.W., et al. Expression of biologically active human thyrotropin (hTSH) in a baculovirus system: effect of insect cell glycosylation on hTSH activity in vitro and in vivo. Endocrinology. 138:1997;92-100
10. Hoogenboom H.R., Griffiths A.D., Johnson K.S., Chiswell D.J., Hudson P., Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19:1991;4133-4137
11. Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.S., Novotny J., Margolies M.N., Ridge R.J., Bruccoleri R.E., Haber E., Crea R., et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5879-5883
12. Kabat, E.A., Wu, T.T., Reid-Miller, M., Perry, H.M., Gottesman, K.S., Foeller, C., 1991. Sequences of Proteins of Immunological Interest. National Institutes of Health, Washington, DC.
13. Kinoshita T., Sato H., Okada A., Ohuchi E., Imai K., Okada Y., Seiki M., et al. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilised on agarose beads. J. Biol. Chem. 273:1998;16098-16103
14. Kirkpatrick R.B., Ganguly S., Angelichio M., Griego S., Shatzman A., Silverman C., Rosenberg M., et al. Heavy chain dimers as well as complete antibodies are efficiently formed and secreted from Drosophila via a BiP-mediated pathway. J. Biol. Chem. 270:1995;19800-19805
15. Kock, M.A., 1996. Expression and characterisation of recombinant cobra venom factor. University of Hamburg, Hamburg, Wissenschaft und Technik Verlag Gross, Berlin, ISBN No. 3-89685-402-X, (US Patent No. 925442, 2001).
16. Lachmann P.J., Halbwachs L. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Clin. Exp. Immunol. 21:1975;109-114
17. Lambris J.D., Avila D., Becherer J.D., Muller-Eberhard H.J. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. J. Biol. Chem. 263:1988;12147-12150
18. Lao Z., Wang Y., Mavroidis M., Kostavasili I., Lambris J.D. Overexpression, purification, and characterisation of third component of complement. J. Immunol. Methods. 176:1994;127-139
19. McCafferty J., Griffiths A.D., Winter G., Chiswell D.J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 348:1990;552-554
20. Medicus R.G., Gotze O., Muller-Eberhard H.J. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J. Exp. Med. 144:1976;1076-1093
21. Muller-Eberhard H.J., Fjellstrom K.E. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J. Immunol. 107:1971;1666-1672
22. O'Keefe M.C., Caporale L.H., Vogel C.W. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. J. Biol. Chem. 263:1988;12690-12697
23. Possee R.D. Cell-surface expression of influenza virus haemagglutinin in insect cells using a baculovirus vector. Virus Res. 5:1986;43-59
24. Sardy M., Odenthal U., Karpati S., Paulsson M., Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin. Chem. 45:1999;2142-2149
25. Skerra A., Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science. 240:1988;1038-1041
26. Schmidt T.G., Koepke J., Frank R., Skerra A. Molecular interaction between the Strep-tag affinity peptide and its cognate target, streptavidin. J. Mol. Biol. 255:1996;753-766
27. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 228:1985;1315-1317
28. Vogel C.W., Muller-Eberhard H.J. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J. Biol. Chem. 257:1982;8292-8299
29. Vogel C.W., Muller-Eberhard H.J. Cobra venom factor: improved method for purification and biochemical characterisation. J. Immunol. Methods. 73:1984;203-220
30. Vogel C.W., Bredehorst R., Fritzinger D.C., Grunwald T., Ziegelmuller P., Kock M.A. Structure and function of cobra venom factor, the complement-activating protein in cobra venom. Adv. Exp. Med. Biol. 391:1996;97-114
31. Wendt U.K., Wenderoth I., Tegeler A., Von Schaewen A. Molecular characterisation of a novel glucose-6-phosphate dehydrogenase from potato (Solanum tuberosum L.). Plant J. 23:2000;723-733
32. Zwicker N., Adelhelm K., Thiericke R., Grabley S., Hanel F. Strep-tag II for one-step affinity purification of active bHLHzip domain of human c-Myc. Biotechniques. 27:1999;368-375